Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NC0G
|
||||
| Former ID |
DIB015964
|
||||
| Drug Name |
RQ-00203066
|
||||
| Synonyms |
Nav1.3 antagonists (pain), RaQualia
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Investigative | [1] | ||
| Company |
RaQualia Pharma Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Voltage-gated sodium channel subunit alpha Nav1.3 | Target Info | Antagonist | [1] | |
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 580). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.